Notice Number: NOT-CA-18-091
Key Dates
Release Date: August 23, 2018
PAR-18-466
Issued by
National Cancer Institute (NCI)
Purpose
The purpose of this Notice is to amend PAR-18-466 "The NCI Transition Career Development Award (K22 Independent Clinical Trial Required)" so that Foreign components can be part of applications from Domestic institutions that are submitted in response to it.
The following specific change is implemented:
Part 2. Section III. Eligibility Information
1. Eligible Applicants
Eligible Organizations
The language towards the end of the bulleted organizations/institutions in this section of PAR-18-466 currently reads as follows:
Foreign Institutions Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
That language has been revised and implemented as follows:
Foreign Institutions Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
All other aspects of this Funding Opportunity Announcement remain unchanged.
Inquiries
Please direct all inquiries to:
Sonia B. Jakowlew, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5630
Email: jakowles@mail.nih.gov
and Human Services (HHS)
